Literature DB >> 2084068

A semi-automated neutral red based chemosensitivity assay for drug screening.

P F Cavanaugh1, P S Moskwa, W H Donish, P J Pera, D Richardson, A P Andrese.   

Abstract

A semi-automated colorimetric chemosensitivity assay was developed. The assay utilizes the vital stain neutral red for the rapid screening of potential anticancer agents using solid tumor cell lines. The cell lines used in this assay and presented in this report are CX-1 colon adenocarcinoma and A549 lung carcinoma. The assay, performed in 96 well tissue culture plates, allows for short drug exposure times (3 hrs.) followed by quantitation of cell number (neutral red absorbance) following four cell doubling times. Cell number directly correlated with absorbance of eluted neutral red at 540 nm. However, optimal amounts of dye and staining times varied between cell lines. IC50 concentrations (for inhibition of cell growth) determined using this assay were in good agreement with results from clonogenic assays using similar drug treatment conditions. The assay technique was determined to be capable of detecting antineoplastic compounds operating by a wide variety of mechanisms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2084068     DOI: 10.1007/BF00198590

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  13 in total

1.  Comparison of in vitro methods to determine drug-induced cell lethality.

Authors:  P R Roper; B Drewinko
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

2.  The pharmacological relevance of vital staining with neutral red.

Authors:  Z Nemes; R Dietz; J B Lüth; S Gomba; E Hackenthal; F Gross
Journal:  Experientia       Date:  1979-11-15

3.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

4.  Model for estimation of clinically achievable plasma concentrations for investigational anticancer drugs in man.

Authors:  W Scheithauer; G M Clark; S E Salmon; W Dorda; R H Shoemaker; D D Von Hoff
Journal:  Cancer Treat Rep       Date:  1986-12

5.  Poly I-Mercapto Poly C: antiviral, anticellular, and pharmacologic effects.

Authors:  K A Vastola; Y K Ho; T J Bardos; B J Grossmayer; L Fruck-Diviak; J A O'Malley
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1984-09

6.  Toxicity determined in vitro by morphological alterations and neutral red absorption.

Authors:  E Borenfreund; J A Puerner
Journal:  Toxicol Lett       Date:  1985 Feb-Mar       Impact factor: 4.372

7.  Use of a radiometric system to screen for antineoplastic agents: correlation with a human tumor cloning system.

Authors:  D D Von Hoff; B Forseth; L E Warfel
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701

8.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability.

Authors:  F Denizot; R Lang
Journal:  J Immunol Methods       Date:  1986-05-22       Impact factor: 2.303

9.  A novel dye exclusion method for testing in vitro chemosensitivity of human tumors.

Authors:  L M Weisenthal; J A Marsden; P L Dill; C K Macaluso
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

10.  Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.

Authors:  D A Scudiero; R H Shoemaker; K D Paull; A Monks; S Tierney; T H Nofziger; M J Currens; D Seniff; M R Boyd
Journal:  Cancer Res       Date:  1988-09-01       Impact factor: 12.701

View more
  11 in total

1.  The ePetri dish, an on-chip cell imaging platform based on subpixel perspective sweeping microscopy (SPSM).

Authors:  Guoan Zheng; Seung Ah Lee; Yaron Antebi; Michael B Elowitz; Changhuei Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

2.  Lens-Free Imaging as a Sensor for Dynamic Cell Viability Detection Using the Neutral Red Uptake Assay.

Authors:  Brian J Nablo; Jung-Joon Ahn; Kiran Bhadriraju; Jong Muk Lee; Darwin R Reyes
Journal:  ACS Appl Bio Mater       Date:  2020

3.  A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays.

Authors:  Jason P Roth; Joseph K-K Li; Donald F Smee; John D Morrey; Dale L Barnard
Journal:  Antiviral Res       Date:  2009-02-02       Impact factor: 5.970

4.  Potent inhibition of respiratory syncytial virus replication using a 2-5A-antisense chimera targeted to signals within the virus genomic RNA.

Authors:  M R Player; D L Barnard; P F Torrence
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

5.  Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae.

Authors:  Barry R O'Keefe; Barbara Giomarelli; Dale L Barnard; Shilpa R Shenoy; Paul K S Chan; James B McMahon; Kenneth E Palmer; Brian W Barnett; David K Meyerholz; Christine L Wohlford-Lenane; Paul B McCray
Journal:  J Virol       Date:  2009-12-23       Impact factor: 5.103

6.  Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin.

Authors:  Yohichi Kumaki; Miles K Wandersee; Aaron J Smith; Yanchen Zhou; Graham Simmons; Nathan M Nelson; Kevin W Bailey; Zachary G Vest; Joseph K-K Li; Paul Kay-Sheung Chan; Donald F Smee; Dale L Barnard
Journal:  Antiviral Res       Date:  2011-02-19       Impact factor: 5.970

7.  Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? Lack of efficacy of promazine on SARS-CoV replication in a mouse model.

Authors:  Dale L Barnard; Craig W Day; Kevin Bailey; Matthew Heiner; Robert Montgomery; Larry Lauridsen; Kie-Hoon Jung; Joseph K-K Li; Paul K S Chan; Robert W Sidwell
Journal:  Antiviral Res       Date:  2008-01-11       Impact factor: 5.970

8.  Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells.

Authors:  Yohichi Kumaki; Craig W Day; Miles K Wandersee; Bradley P Schow; Justin S Madsen; Dixon Grant; Jason P Roth; Donald F Smee; Lawrence M Blatt; Dale L Barnard
Journal:  Biochem Biophys Res Commun       Date:  2008-04-10       Impact factor: 3.575

9.  Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.

Authors:  Dale L Barnard; Craig W Day; Kevin Bailey; Matthew Heiner; Robert Montgomery; Larry Lauridsen; Scott Winslow; Justin Hoopes; Joseph K-K Li; Jongdae Lee; Dennis A Carson; Howard B Cottam; Robert W Sidwell
Journal:  Antiviral Res       Date:  2006-03-24       Impact factor: 5.970

10.  Global Transcriptional Analysis of Nontransformed Human Intestinal Epithelial Cells (FHs 74 Int) after Exposure to Selected Drinking Water Disinfection By-Products.

Authors:  Erik Procházka; Steven D Melvin; Beate I Escher; Michael J Plewa; Frederic D L Leusch
Journal:  Environ Health Perspect       Date:  2019-11-22       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.